vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -98.30% | -- | 11,011.11% | 11,011.11% | 5,455.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -98.30% | -- | 11,011.11% | 11,011.11% | 5,455.56% |
| Cost of Revenue | -166.43% | -139.64% | -47.90% | -52.60% | -61.01% |
| Gross Profit | 183.33% | 151.12% | 57.09% | 61.61% | 68.57% |
| SG&A Expenses | 7.63% | 14.65% | 15.51% | 8.39% | 19.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.50% | -1.20% | -7.93% | -13.15% | 5.10% |
| Operating Income | -5.71% | 5.18% | 11.58% | 16.76% | -0.92% |
| Income Before Tax | 12.29% | 12.94% | 18.13% | -3.12% | -21.88% |
| Income Tax Expenses | -100.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.62% | 12.56% | 17.77% | -3.53% | -22.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.68% | -25.77% | -27.80% | -3.45% | 17.37% |
| Net Income | 9.35% | 8.83% | 14.92% | -5.51% | -23.78% |
| EBIT | -5.71% | 5.18% | 11.58% | 16.76% | -0.92% |
| EBITDA | -5.79% | 5.20% | 11.62% | 16.81% | -0.93% |
| EPS Basic | 63.78% | 69.14% | 60.35% | 30.88% | 0.97% |
| Normalized Basic EPS | 62.37% | 71.25% | 61.99% | 35.13% | 8.01% |
| EPS Diluted | 63.78% | 69.14% | 60.35% | 30.88% | 0.97% |
| Normalized Diluted EPS | 62.37% | 71.25% | 61.99% | 35.13% | 8.01% |
| Average Basic Shares Outstanding | 97.70% | 197.91% | 145.39% | 106.55% | 60.36% |
| Average Diluted Shares Outstanding | 97.70% | 197.91% | 145.39% | 106.55% | 60.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |